ANALYSIS OF THE BINDING-SITE ARCHITECTURE OF MONOCLONAL-ANTIBODIES TO MORPHINE BY USING COMPETITIVE LIGAND-BINDING AND MOLECULAR MODELING

被引:0
|
作者
KUSSIE, PH
ANCHIN, JM
SUBRAMANIAM, S
GLASEL, JA
LINTHICUM, DS
机构
[1] TEXAS A&M UNIV SYST, COLL VET MED, DEPT VET PATHOBIOL, COLLEGE STN, TX 77843 USA
[2] UNIV TEXAS, HLTH SCI CTR, DEPT PATHOL & LAB MED, HOUSTON, TX 77225 USA
[3] UNIV CONNECTICUT, DEPT BIOCHEM, FARMINGTON, CT 06032 USA
来源
JOURNAL OF IMMUNOLOGY | 1991年 / 146卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The structural features of mAb directed against the opiate morphine were analyzed by using competitive ligand analog-binding studies, examination of the V region amino acid sequence, and computer-aided molecular modeling of the fragment V region. The antibody response in BALB/c mice to morphine is relatively restricted, in that all of the mAb examined in this study contained the same lambda-L chain and very similar H chain V regions. A three-dimensional model of the antimorphine-binding site was constructed by using computational and graphic display techniques. Each of the six complementarity-determining regions was constructed by using fragment replacement methods employing canonical loop conformations of known "parent" structures. Experimental competitive ligand-binding data and theoretical modeling suggest that a charged glutamate residue at position H:50 and aromatic side chains of residues H:33W, H:47W, H:58F, H:95W, H:10liY, and L:91W are key features in ionic and hydrophobic interactions with the ligand. This study represents the first use of theoretical and experimental modeling techniques to describe the Ag-binding site of a mouse fragment V region containing a lambda-L chain.
引用
收藏
页码:4248 / 4257
页数:10
相关论文
共 50 条
  • [21] MICROPHARMACOLOGY OF MONOCLONAL-ANTIBODIES IN SOLID TUMORS - DIRECT EXPERIMENTAL-EVIDENCE FOR A BINDING-SITE BARRIER
    JUWEID, M
    NEUMANN, R
    PAIK, C
    PEREZBACETE, MJ
    SATO, J
    VANOSDOL, W
    WEINSTEIN, JN
    CANCER RESEARCH, 1992, 52 (19) : 5144 - 5153
  • [22] LOCALIZATION ON HUMAN TRANSFERRIN OF ITS BINDING-SITE TO THE CELL-RECEPTOR WITH THE AID OF MONOCLONAL-ANTIBODIES
    RUBIKAITE, VI
    BERESTEN, SF
    VIKLITSKII, V
    SLAVICHKOVA, A
    MOLECULAR BIOLOGY, 1991, 25 (01) : 155 - 162
  • [23] MOLECULAR MODELING OF LIGAND INTERACTIONS WITH THE CGMP BINDING-SITE FROM RETINAL CHANNELS
    SCOTT, SP
    EPSTEIN, AJ
    LOPEZ, MC
    TANAKA, JC
    BIOPHYSICAL JOURNAL, 1994, 66 (02) : A437 - A437
  • [24] MONOCLONAL-ANTIBODIES AGAINST 2 PEPTIDE SEQUENCES OF THE ACETYLCHOLINE-RECEPTOR DISTINGUISH BETWEEN TOXIN BINDING AND CHOLINERGIC LIGAND-BINDING
    FAIRCLOUGH, RH
    MIHOVILOVIC, M
    KEZDY, FJ
    RICHMAN, DP
    JOURNAL OF NEUROIMMUNOLOGY, 1987, 16 (01) : 54 - 54
  • [25] ENGINEERING HUMAN-ANTIBODIES TO THE INTEGRIN LIGAND-BINDING SITE
    SMITH, JW
    BARBAS, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S178 - S178
  • [26] LIGAND-BINDING TO ANTI-FLUORESCYL ANTIBODIES - STABILITY OF THE ANTIGEN-BINDING SITE
    MULLER, JD
    NIENHAUS, GU
    TETIN, SY
    VOSS, EW
    BIOCHEMISTRY, 1994, 33 (20) : 6221 - 6227
  • [27] DIFFERENCE METHOD OF LIGAND-BINDING ANALYSIS - DISTINGUISHING SUPERHIGH-AFFINITY OPIATE LIGAND-BINDING SITE
    ZAITSEV, SV
    KUROCHKIN, IN
    VARFOLOMEEV, SD
    BEREZIN, IV
    DOKLADY AKADEMII NAUK SSSR, 1985, 281 (03): : 727 - 731
  • [28] Molecular modeling of the GABAc receptor ligand-binding domain
    Harrison, NJ
    Lummis, SCR
    JOURNAL OF MOLECULAR MODELING, 2006, 12 (03) : 317 - 324
  • [29] Molecular modeling of the GABAC receptor ligand-binding domain
    Neil J. Harrison
    Sarah C.R. Lummis
    Journal of Molecular Modeling, 2006, 12 : 317 - 324
  • [30] MONOCLONAL-ANTIBODIES TO TORPEDO ACETYLCHOLINE-RECEPTOR - CHARACTERIZATION OF ANTIGENIC DETERMINANTS WITHIN THE CHOLINERGIC BINDING-SITE
    WHITING, P
    VINCENT, A
    NEWSOMDAVIS, J
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 150 (03): : 533 - 539